Back

Impact of Discoordinated Care on Healthcare Utilization and Survival in Stage IV Non-Small Cell Lung Cancer Patients

Heilbroner, S. P.; Xanthopoulos, E. P.; Hoffman, M. A.; Buono, D.; Durkee, B. Y.; Corradetti, M.; Wang, T. J.; Wright, J. D.; Neugut, A. I.; Hershman, D. L.; Rohs, N. C.; Cheng, S. K.

2021-01-02 oncology
10.1101/2020.12.28.20248904 medRxiv
Show abstract

BackgroundCancer patients treatment is often dispersed across multiple physician communities that may not exchange information. We measured the association between this type of discoordinated care and healthcare utilization, cost, and mortality in stage IV non-small cell lung cancer (NSCLC). MethodsStage IV NSCLC patients [≥]65 years were identified from the Surveillance, Epidemiology, and End Results database attached to Medicare claims. A discoordinated care subgroup was selected using a novel index that approximated how many physician communities each patient encountered. Communities were defined by (1) using claims data to create a nationwide social network of healthcare providers and then (2) dividing that network into communities using cluster label propagation. Associations between discoordinated care and overall survival (OS), cancer-specific survival (CSS), hospitalizations, the burden of diagnostic imaging, and cost were assessed. ResultsOf the 11,417 patients in our cohort, 5,855 received discoordinated care. Discoordination was associated with younger age, higher socioeconomic status, higher physician density, and lack of a home health aide. Discoordinated care was associated with improved OS and CSS (HR = 0.92, 95% CI 0.88 - 0.95 for OS). However, discoordinated patients also received 32% more MRIs (p = 0.007) and paid $494.02 more for imaging (p = 0.004). There was no association with other kinds of imaging, rates of hospitalization, or other healthcare costs, including total cost. ConclusionsDiscoordinated care was associated with additional MRIs, but also improved survival. The reason is unclear, but discoordinated patients may be seeking the best care at the expense of continuity. Key PointsO_ST_ABSQuestionC_ST_ABSHow does dispersing healthcare across multiple physician communities impact healthcare utilization and survival in patients with advanced stage non-small cell lung cancer? FindingsIn this retrospective cohort study, we found that discoordinated care was associated with increased utilization of MRIs and total cost of imaging. Surprisingly, it was also associated with improved survival. MeaningCancer patients with dispersed healthcare may be seeking care through a tertiary care center or clinical trial. This may lead to increased healthcare utilization but also improved survival.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
JAMA Network Open
127 papers in training set
Top 0.1%
26.8%
2
PLOS ONE
4510 papers in training set
Top 17%
10.4%
3
BMJ Open
554 papers in training set
Top 2%
8.7%
4
Annals of Epidemiology
19 papers in training set
Top 0.1%
4.5%
50% of probability mass above
5
Scientific Reports
3102 papers in training set
Top 26%
4.5%
6
EClinicalMedicine
21 papers in training set
Top 0.1%
3.2%
7
Frontiers in Oncology
95 papers in training set
Top 1%
2.8%
8
PeerJ
261 papers in training set
Top 4%
2.5%
9
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.2%
2.4%
10
Annals of Oncology
13 papers in training set
Top 0.3%
2.1%
11
International Journal of Cancer
42 papers in training set
Top 0.5%
2.0%
12
JNCI Cancer Spectrum
10 papers in training set
Top 0.2%
1.8%
13
The Lancet Regional Health - Americas
22 papers in training set
Top 0.1%
1.8%
14
International Journal of Radiation Oncology*Biology*Physics
21 papers in training set
Top 0.3%
1.4%
15
eLife
5422 papers in training set
Top 48%
1.3%
16
BJGP Open
12 papers in training set
Top 0.5%
1.1%
17
BMC Infectious Diseases
118 papers in training set
Top 4%
1.0%
18
Journal of Translational Medicine
46 papers in training set
Top 2%
1.0%
19
Cancer Medicine
24 papers in training set
Top 1%
1.0%
20
Cancers
200 papers in training set
Top 4%
0.9%
21
JCO Clinical Cancer Informatics
18 papers in training set
Top 0.7%
0.9%
22
BMC Health Services Research
42 papers in training set
Top 2%
0.8%
23
Cancer Letters
32 papers in training set
Top 0.8%
0.7%
24
British Journal of Cancer
42 papers in training set
Top 2%
0.7%
25
JCO Precision Oncology
14 papers in training set
Top 0.5%
0.7%
26
Nature Communications
4913 papers in training set
Top 65%
0.7%
27
Cancer Cell
38 papers in training set
Top 2%
0.7%
28
Health Expectations
12 papers in training set
Top 0.8%
0.5%
29
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.8%
0.5%
30
Journal of General Internal Medicine
20 papers in training set
Top 1%
0.5%